LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 63.15 | 17.25 | 2490 | 5061 | 0.4920 | 0.8342 | MN20160310_N02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 63.15 | 17.25 | 10 | 5061 | 0.0020 | -0.0644 | MN20160310_N02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 63.15 | 17.25 | 2058 | 5061 | 0.4066 | 0.7921 | MN20160310_N02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 65.12 | 17.25 | 2572 | 5095 | 0.5048 | 0.8401 | MN20160310_N02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 65.12 | 17.25 | 2618 | 5095 | 0.5138 | 0.8441 | MN20160310_N02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 65.12 | 17.25 | 8 | 5095 | 0.0016 | -0.0894 | MN20160310_N02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 65.12 | 17.25 | 2051 | 5095 | 0.4025 | 0.7901 | MN20160310_N02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 67.09 | 17.25 | 2631 | 5221 | 0.5039 | 0.8404 | MN20160310_N02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 67.09 | 17.25 | 2677 | 5221 | 0.5127 | 0.8443 | MN20160310_N02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 67.09 | 17.25 | 12 | 5221 | 0.0023 | -0.0431 | MN20160310_N02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 67.09 | 17.25 | 2187 | 5221 | 0.4189 | 0.7996 | MN20160310_N02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 69.06 | 17.25 | 2763 | 5242 | 0.5270 | 0.8506 | MN20160310_N02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 69.06 | 17.25 | 2825 | 5242 | 0.5389 | 0.8555 | MN20160310_N02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 69.06 | 17.25 | 14 | 5242 | 0.0027 | -0.0250 | MN20160310_N02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 69.06 | 17.25 | 2074 | 5242 | 0.3956 | 0.7873 | MN20160310_N02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 71.03 | 17.25 | 2885 | 5367 | 0.5375 | 0.8556 | MN20160310_N02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 71.03 | 17.25 | 2923 | 5367 | 0.5446 | 0.8585 | MN20160310_N02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 71.03 | 17.25 | 10 | 5367 | 0.0019 | -0.0637 | MN20160310_N02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 71.03 | 17.25 | 2237 | 5367 | 0.4168 | 0.7994 | MN20160310_N02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 73.00 | 17.25 | 3047 | 5546 | 0.5493 | 0.8612 | MN20160310_N02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 73.00 | 17.25 | 3078 | 5546 | 0.5549 | 0.8635 | MN20160310_N02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 73.00 | 17.25 | 18 | 5546 | 0.0032 | 0.0051 | MN20160310_N02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 73.00 | 17.25 | 2336 | 5546 | 0.4211 | 0.8028 | MN20160310_N02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 74.97 | 17.25 | 3116 | 5618 | 0.5546 | 0.8636 | MN20160310_N02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 74.97 | 17.25 | 3145 | 5618 | 0.5597 | 0.8657 | MN20160310_N02 | G10 |